192 related articles for article (PubMed ID: 15386348)
1. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma.
Nakashima K; Shimada H; Ochiai T; Kuboshima M; Kuroiwa N; Okazumi S; Matsubara H; Nomura F; Takiguchi M; Hiwasa T
Int J Cancer; 2004 Dec; 112(6):1029-35. PubMed ID: 15386348
[TBL] [Abstract][Full Text] [Related]
2. Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma.
Shimada H; Shiratori T; Yasuraoka M; Kagaya A; Kuboshima M; Nomura F; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
BMC Cancer; 2009 Jul; 9():232. PubMed ID: 19604354
[TBL] [Abstract][Full Text] [Related]
3. Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma.
Kuboshima M; Shimada H; Liu TL; Nomura F; Takiguchi M; Hiwasa T; Ochiai T
Cancer Sci; 2006 May; 97(5):380-6. PubMed ID: 16630135
[TBL] [Abstract][Full Text] [Related]
4. Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma: a possible new serum marker for esophageal cancer.
Shimada H; Kagaya A; Shiratori T; Nomura F; Takiguchi M; Matsubara H; Hiwasa T
J Gastroenterol; 2009; 44(7):691-6. PubMed ID: 19407926
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
Shimada H; Kuboshima M; Shiratori T; Nabeya Y; Takeuchi A; Takagi H; Nomura F; Takiguchi M; Ochiai T; Hiwasa T
Int J Oncol; 2007 Jan; 30(1):97-103. PubMed ID: 17143517
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
Kuboshima M; Shimada H; Liu TL; Nakashima K; Nomura F; Takiguchi M; Hiwasa T; Ochiai T
Int J Oncol; 2006 Feb; 28(2):463-8. PubMed ID: 16391802
[TBL] [Abstract][Full Text] [Related]
7. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
[TBL] [Abstract][Full Text] [Related]
8. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
Pak MG; Shin DH; Lee CH; Lee MK
World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.
Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J
Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366
[TBL] [Abstract][Full Text] [Related]
10. Correlation between laminin-5 gamma2 chain and epidermal growth factor receptor expression in esophageal squamous cell carcinomas.
Fukai Y; Masuda N; Kato H; Fukuchi M; Miyazaki T; Nakajima M; Sohda M; Kuwano H; Nakajima T
Oncology; 2005; 69(1):71-80. PubMed ID: 16103736
[TBL] [Abstract][Full Text] [Related]
11. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
12. Decrease in chemosensitivity against anticancer drugs by an esophageal squamous cell carcinoma SEREX antigen, AISEC.
Hiwasa T; Shimada H; Kuboshima M; Shiratori T; Kagaya A; Nabeya Y; Sugano S; Ochiai T; Matsubara H; Takiguchi M
Int J Oncol; 2009 Mar; 34(3):641-8. PubMed ID: 19212668
[TBL] [Abstract][Full Text] [Related]
13. Association of Kruppel-like factor 4 expression with the prognosis of esophageal squamous cell carcinoma patients.
Ma MQ; Zhang HD; Tang P; Jiang HJ; Chen CG
Int J Clin Exp Pathol; 2014; 7(10):6679-85. PubMed ID: 25400747
[TBL] [Abstract][Full Text] [Related]
14. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
16. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
[TBL] [Abstract][Full Text] [Related]
17. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.
Fang YJ; Lu ZH; Wang GQ; Pan ZZ; Zhou ZW; Yun JP; Zhang MF; Wan DS
Int J Colorectal Dis; 2009 Aug; 24(8):875-84. PubMed ID: 19421758
[TBL] [Abstract][Full Text] [Related]
18. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
20. [The expressions and diagnostic values of miR-18a and miR-21 in esophageal cancer].
Yao LH; Wang GR; Cai Y; Ma Q; Wang DS; Xu L; Guo XL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):107-111. PubMed ID: 30862139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
